Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months

ClinicalTrials.gov ID: NCT03351244

Public ClinicalTrials.gov record NCT03351244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 4:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered BI 409306 During a 28-week Treatment Period as Adjunctive Therapy to Antipsychotic Treatment for the Prevention of Relapse in Patients With Schizophrenia.

Study identification

NCT ID
NCT03351244
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Boehringer Ingelheim
Industry
Enrollment
264 participants

Conditions and interventions

Conditions

Interventions

  • BI 409306 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 6, 2017
Primary completion
Mar 9, 2021
Completion
Mar 30, 2021
Last update posted
May 13, 2025

2017 – 2021

United States locations

U.S. sites
32
U.S. states
13
U.S. cities
30
Facility City State ZIP Site status
Alea Research Phoenix Arizona 85012
ATP Clinical Research, Inc. Costa Mesa California 92626
Collaborative Neuroscience Network, LLC (CNS) Garden Grove California 92845
Behavioral Research Specialists, LLC Glendale California 91206
Synergy East Lemon Grove California 91945
University of California Los Angeles Los Angeles California 90095
Excell Research Inc. Oceanside California 92056
Orange County Neuropsychiatric Research Center LLC Orange California 92868
Collaborative Neuroscience Network, LLC (CNS) Torrance California 90502
MD Clinical Hallandale Florida 33009
Reliable Clinical Research Hialeah Florida 33012
Meridien Research Maitland Florida 32751
Behavioral Clinical Research, Inc. North Miami Florida 33161
Meridien Research Orlando Florida 32810
Atlanta Center Atlanta Georgia 30331
Alam Medical Research, Inc. Chicago Illinois 60612
Lake Charles Clinical Trials LLC Lake Charles Louisiana 70629
Clinical Trials of America, LLC Monroe Louisiana 71201
Michigan Clinical Research Institute PC Ann Arbor Michigan 48105
Precise Research Centers Flowood Mississippi 39232
St. Charles Psychiatric Associates & Midwest Research Group Saint Charles Missouri 63304
Arch Clinical Trials St Louis Missouri 63125
PsychCare Consultants Research St Louis Missouri 63128
Altea Research Institute Las Vegas Nevada 89102
Hassman Research Institute Berlin New Jersey 08009
Neurobehavioral Research, Inc. Cedarhurst New York 11516
New York State Psychiatric Institute New York New York 10032
Manhattan Behavioral Medicine PLLC New York New York 10036
Community Clinical Research, Inc. Austin Texas 78754
University Hills Clinical Research Irving Texas 75062
Pillar Clinical Research, LLC Richardson Texas 75080
@Health Texas Richmond Texas 77407

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03351244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2025 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03351244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →